Summary
Hepatotoxicity secondary to the administration of thiabendazole has been rare since this drug was produced in 1964. In 14 of 15 patients reported previously in the literature, severe intrahepatic cholestasis resolved within seven months of the onset of illness. A recent report documented the progression to cirrhosis in a 15th patient. We report the second case of a patient with intrahepatic cholestasis that developed after treatment with thiabendazole and progressed to severe micronodular cirrhosis.
Similar content being viewed by others
References
Hennekeuser HH, Pabst K, Poeplau W, Gerok W: Thiabendazole for the treatment of trichinosis in humans. Tex Rep Biol Med 27(suppl 2):581–596, 1969
Bayles MAH: Chromomycosis: Treatment with thiabendazole. Arch Dermatol 104:476–485, 1971
Jalota R, Freston JW: Severe intrahepatic cholestasis due to thiabendazole. Am J Trop Med Hyg 23:676–678, 1974
Feregrino GM, Lifshitz GA, Hernandez BA, Ramirez DJ, Cervantes LF: Coléstasis intrahepatic por thiabendazol tratada con fenobarbital. Prensa Med Mex 41:167–171, 1976
Fink AI, MacKay CJ, Cutler SS: Sicca complex and cholangiostatic jaundice in two members of a family probably caused by thiabendazole. Ophthalmology (Rochester) 86:1892–1896, 1979
Rex D, Lumeng L, Eble J, Rex L: Intrahepatic cholestasis and sicca complex after thiabendazole: Report of a case and review of the literature. Gastroenterology 85:718–721 1983
Manivel JC, Bloomer JR, Snover DC: Progressive bile duct injury after thiabendazole administration. Gastroenterology 93:245–249, 1987
Zimmerman HJ: Hepatotoxicity. New York, Appleton-Century-Crofts, 1978, pp 468–509
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roy, M.A., Nugent, F.W. & Aretz, H.T. Micronodular cirrhosis after thiabendazole. Digest Dis Sci 34, 938–941 (1989). https://doi.org/10.1007/BF01540282
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01540282